Board MeetingJul 29, 2026, 04:09 PM
Revolution Medicines Q2 2026 Earnings Call Scheduled for Aug 5
AI Summary
Revolution Medicines, Inc. announced it will report its financial results for the second quarter of 2026 on Wednesday, August 5, 2026, after market close. Following the release, the company's senior management will host a webcast and conference call at 4:30 p.m. ET to discuss the results and provide a corporate update. Interested parties can access the live and archived webcast via the company's investor relations website.
Key Highlights
- Revolution Medicines to report Q2 2026 financial results after market close on Wednesday, August 5, 2026.
- A webcast and conference call will be hosted by senior management at 4:30 p.m. ET (1:30 p.m. PT) on August 5, 2026.
- The webcast will discuss financial results and provide an update on corporate progress.
- Live webcast access and archived replay will be available on the company's investor relations website.
- The replay will be available for at least 14 days following the live webcast.
Price Impact
More from RVMD
Quarterly Result1d ago, 4:20 PM
Revolution Medicines Q2 Net Loss $(644.4)M; Raises $1.65B in Offering
Quarterly Result1d ago, 4:13 PM
Revolution Medicines Q2 Net Loss $644.4M; FDA Accepts Daraxonrasib NDA
Quarterly Result1d ago, 4:04 PM
Revolution Medicines: FDA Accepts Daraxonrasib NDA; Breakthrough Status